Cargocytes achieve targeted delivery of potent therapeutics specifically at disease sites and shift the paradigm of how patients are treated. They’re designed to overcome restrictive barriers and penetrate hard-to-treat tissues where limited therapeutic success has been observed, especially for patients with critical unmet needs.

Using Cytonus’ propriety AI tools, Cargocytes have unlimited engineering potential in creating best-in-class therapeutics for any given clinical application. Along with robust manufacturing that yields a consistent and reproducible product, they’re designed to be allogeneic (can be given to any patient) and can be produced at large scale for off-the-shelf access.